Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
RX
RxSight, Inc. Common Stock
RXST
Mkt Cap
$187.8M
Volume
983.77K
Next Earnings
November 4th
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
RX
RXST
RX
RxSight, Inc. Common Stock
RXST
News
·
K2 Vision Has Been Recognized as the Highest-Volume Light Adjustable Lens practice in the world
Mkt Cap
$194.2M
Volume
983.77K
Next Earnings
November 4th
Chart
Financials
Earnings
News
About
Insider
Filings
K2 Vision Has Been Recognized as the Highest-Volume Light Adjustable Lens practice in the world
K2 Vision, a Pacific Northwest and Arizona-based vision correction practice, has completed 5,000 Light Adjustable Lens (LAL) procedures and been recognized by RxSight as the world's highest-volume LAL practice. The LAL is the first lens implant that can be adjusted after placement through noninvasive light treatments, allowing for customized vision correction based on patient needs.
GlobeNewswire Inc. · Oct 16, 2026
RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer
RxSight, Inc. announced preliminary 2025 full-year revenue of $134.5 million, exceeding guidance, driven by 109,615 Light Adjustable Lens procedures (12% increase YoY) and expansion of its installed base to 1,134 Light Delivery Devices. The company also appointed Mark Wilterding as Chief Financial Officer, bringing 25+ years of medtech financial leadership experience from Edwards Lifesciences.
GlobeNewswire Inc. · Jan 11, 2026
RxSight, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - RXST
DJS Law Group is investigating RxSight, Inc. for potential securities law violations after the company reported significant financial declines, including reduced sales of Light Delivery Devices and lowered annual financial guidance.
Benzinga · Sep 22, 2025
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight
Faruqi & Faruqi is investigating potential securities law violations by RxSight after the company reported significant sales declines and lowered financial guidance, causing its stock price to drop 37.8%.
GlobeNewswire Inc. · Sep 21, 2025
מחר המועד האחרון לתביעה נגד RXST: רוזן, יועץ למשקיעים מוביל, מעודד משקיעים ב- .RxSight, Inc עם הפסדים של יותר מ-100 אלף דולר להבטיח ייעוץ לפני המועד האחרון החשוב של 22 בספטמבר בתביעה ייצוגית בניירות ערך - RXST
Rosen Law Firm reminds RxSight investors who purchased securities between May 7, 2024 and July 8, 2025 about an upcoming September 22, 2025 deadline for a securities class action lawsuit, alleging the company misrepresented its growth potential and market performance.
GlobeNewswire Inc. · Sep 21, 2025
RXST DEADLINE TOMORROW: ROSEN, LEADING INVESTOR COUNSEL, Encourages RxSight, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 22 Deadline in Securities Class Action – RXST
Rosen Law Firm is alerting RxSight investors about a September 22, 2025 deadline for a securities class action lawsuit, alleging the company made false statements about customer adoption and growth metrics.
GlobeNewswire Inc. · Sep 21, 2025
מחר המועד האחרון לתביעה נגד REPL: רוזן, יועץ למשקיעים מיומן, מעודד את משקיעי Replimune Group, Inc. שצברו הפסדים של יותר מ- 100 אלף דולר להבטיח ייעוץ לפני המועד האחרון החשוב בתביעה ייצוגית בניירות ערך שהוגשה ראשונה על ידי המשרד – REPL
Rosen Law Firm alerts investors of Replimune Group and RxSight who suffered losses over $100,000 about an upcoming September 22, 2025 deadline for filing securities class action lawsuits related to allegedly misleading statements.
GlobeNewswire Inc. · Sep 21, 2025
INVESTOR CLASS ACTION: RxSight, Inc. Investors are Reminded of the Ongoing Securities Fraud Lawsuit after Stock Plummeted 38% -- Contact BFA Law
RxSight, a medical device company specializing in light adjustable intraocular lenses, faces a securities fraud lawsuit after experiencing significant stock declines due to reported adoption challenges and market softening in its product line.
GlobeNewswire Inc. · Sep 20, 2025
RXST Investors Have Opportunity to Lead RxSight, Inc. Securities Fraud Lawsuit with the Schall Law Firm
The Schall Law Firm is pursuing a class action lawsuit against RxSight, Inc. for alleged securities fraud, claiming the company made false and misleading statements about its financial performance and product demand between November 2024 and July 2025.
Benzinga · Sep 18, 2025
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight
Faruqi & Faruqi is investigating potential securities claims against RxSight after the company reported significant sales declines and lowered financial guidance, causing its stock price to drop 37.8%.
GlobeNewswire Inc. · Sep 18, 2025
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
RX
RXST
RxSight, Inc. Common Stock
Buy
Sell
Market
Limit
Soon
RXST
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any RXST yet.
Related Tickers
Earnings